aTyr Pharma appoints Eric Benevich to the company’s Board

aTyr Pharma (ATYR) announced the appointment of Eric Benevich to the Company’s Board of Directors, effective as of December 10. Mr. Benevich currently serves as Chief Commercial Officer at Neurocrine Biosciences. “We are excited to welcome Eric Benevich to the Board of Directors,” said Timothy P. Coughlin, Chairman of the Board of aTyr. “His extensive background bringing new products to market and the knowledge and expertise he has gained from both building and leading commercial activities at biopharmaceutical companies will be an invaluable resource as aTyr continues its evolution towards commercialization.”